Étude rétrospective de l’efficacité du Protopic® (tacrolimus) dans le traitement de la langue géographique algique

Stéphanie Haddad; Franck Boralévi; Sylvain Catros; Jean-Christophe Fricain

doi:10.1051/mbcb/2015020

Home

All issues

Volume 21 / No 2 (avril 2015)

Med Buccale Chir Buccale, 21 2 (2015) 85-89

References

Open Access

Issue		Med Buccale Chir Buccale Volume 21, Number 2, avril 2015


Page(s)		85 - 89
Section		Article original / Original article
DOI		https://doi.org/10.1051/mbcb/2015020
Published online		01 May 2015

Fricain J-C. Une lésion mystérieuse : La langue géographique 2012. Info Dent 2012;94:22-5. [Google Scholar]
Ishibashi M, Tojo G, Watanabe M, Tamabuchi T, Masu T, Aiba S. Geographic tongue treated with topical tacrolimus. J Dermatol Case Rep 2010;4(4):57-9. [CrossRef] [PubMed] [Google Scholar]
Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign migratory glossitis or geographic tongue: an enigmatic oral lesion. Am J Med 2002;113(9):751-5. [CrossRef] [PubMed] [Google Scholar]
Purani JM, Purani HJ. Treatment of geographic tongue with topical tacrolimus. BMJ Case Rep 2014; doi:10.1136/bcr-2013-201268. [Google Scholar]
Hugues M-L, Debray D, Dorent D, Hiesse C, Samuel D. Tacrolimus (FK506). Le point sur. Dossier de CNHIM (centre national hospitalier d’information sur le médicament) Dossier 1996, XVII, 4. Service pharmacie groupe hospitalier Pitié-Salpétrière Paris. [Google Scholar]
Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002;16(2):100-14. [CrossRef] [PubMed] [Google Scholar]
Resende JP, Chaves MD, Aarestrup FM, Aarestrup BV, Olate S, Netto HD. Oral lichen planus treated with tacrolimus 0.1%. Int J Clin Exp Med 2013;6(10):917-21. [PubMed] [Google Scholar]
Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology 2007;215:45-54. [CrossRef] [Google Scholar]
Lazaro P. Current findings in geographic tongue. Inf Dent 1983;65(20):1759-67. [PubMed] [Google Scholar]
Helfam RJ. The treatment of geographic tongue with topical Retin-A solution. Cutis 1979;24(2):179-80. [PubMed] [Google Scholar]
Casper U, Seiffert K, Dippel E, Zouboulis CC. Exfoliato areata linguae et mucosa oris: a mucous membrane manifestation of psoriasis pustulosa? Hautarzt 1998;49(11):850-4. [CrossRef] [PubMed] [Google Scholar]
Abe M, Sogabe Y, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Successful treatment with Cyclosporin administration for persitant benign migratory glossitis. J Dermatol 2007;34:340-3. [CrossRef] [PubMed] [Google Scholar]
HAS 2008 Commission de la transparence. Avis 28 mai 2008. Examen du dossier des spécialités inscrites pour une durée de 5 ans par arrêté́ du 25 avril 2003 (JO du 15 mai 2003) Protopic 0,03 %, pommade Tube de 30 g (CIP : 359 221-9) Protopic 0,1 %, pommade Tube de 30 g (CIP : 359 223-1). www.astellas.fr/media/cms_page_media/.../2008_05_28_protopic.pdf [Google Scholar]
Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg 2012;16(4):221-9. [PubMed] [Google Scholar]
Eckardt A, Volker B, Starke O, Kaever V, Kapp A. Topical Tacrolimus in erosive oral lichen planus: An effective treatment approach. Oral Bioscience and Medicine 2005;4:235-40. [Google Scholar]
Rouxel AM, Le Toux G, Misery L. Tacrolimus en bains de bouche dans le traitement de seconde intention du lichen plan buccal érosif. Ann Dermatol Venereol 2010;137(10):648-9. [CrossRef] [PubMed] [Google Scholar]
Baubion E, Doutre MS, Beylot-Barry M. Lichen plan buccal et tacrolimus en bains de bouche. Ann Dermatol Venereol 2009; 136(3):276-8. [CrossRef] [PubMed] [Google Scholar]
Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 2002;138:1335-8. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.

[1] Fricain J-C. Une lésion mystérieuse : La langue géographique 2012. Info Dent 2012;94:22-5. [Google Scholar]

[2] Ishibashi M, Tojo G, Watanabe M, Tamabuchi T, Masu T, Aiba S. Geographic tongue treated with topical tacrolimus. J Dermatol Case Rep 2010;4(4):57-9. [CrossRef] [PubMed] [Google Scholar]

[3] Assimakopoulos D, Patrikakos G, Fotika C, Elisaf M. Benign migratory glossitis or geographic tongue: an enigmatic oral lesion. Am J Med 2002;113(9):751-5. [CrossRef] [PubMed] [Google Scholar]

[4] Purani JM, Purani HJ. Treatment of geographic tongue with topical tacrolimus. BMJ Case Rep 2014; doi:10.1136/bcr-2013-201268. [Google Scholar]

[5] Hugues M-L, Debray D, Dorent D, Hiesse C, Samuel D. Tacrolimus (FK506). Le point sur. Dossier de CNHIM (centre national hospitalier d’information sur le médicament) Dossier 1996, XVII, 4. Service pharmacie groupe hospitalier Pitié-Salpétrière Paris. [Google Scholar]

[6] Gupta AK, Adamiak A, Chow M. Tacrolimus: a review of its use for the management of dermatoses. J Eur Acad Dermatol Venereol 2002;16(2):100-14. [CrossRef] [PubMed] [Google Scholar]

[7] Resende JP, Chaves MD, Aarestrup FM, Aarestrup BV, Olate S, Netto HD. Oral lichen planus treated with tacrolimus 0.1%. Int J Clin Exp Med 2013;6(10):917-21. [PubMed] [Google Scholar]

[8] Luger T, Paul C. Potential new indications of topical calcineurin inhibitors. Dermatology 2007;215:45-54. [CrossRef] [Google Scholar]

[9] Lazaro P. Current findings in geographic tongue. Inf Dent 1983;65(20):1759-67. [PubMed] [Google Scholar]

[10] Helfam RJ. The treatment of geographic tongue with topical Retin-A solution. Cutis 1979;24(2):179-80. [PubMed] [Google Scholar]

[11] Casper U, Seiffert K, Dippel E, Zouboulis CC. Exfoliato areata linguae et mucosa oris: a mucous membrane manifestation of psoriasis pustulosa? Hautarzt 1998;49(11):850-4. [CrossRef] [PubMed] [Google Scholar]

[12] Abe M, Sogabe Y, Syuto T, Ishibuchi H, Yokoyama Y, Ishikawa O. Successful treatment with Cyclosporin administration for persitant benign migratory glossitis. J Dermatol 2007;34:340-3. [CrossRef] [PubMed] [Google Scholar]

[13] HAS 2008 Commission de la transparence. Avis 28 mai 2008. Examen du dossier des spécialités inscrites pour une durée de 5 ans par arrêté́ du 25 avril 2003 (JO du 15 mai 2003) Protopic 0,03 %, pommade Tube de 30 g (CIP : 359 221-9) Protopic 0,1 %, pommade Tube de 30 g (CIP : 359 223-1). www.astellas.fr/media/cms_page_media/.../2008_05_28_protopic.pdf [Google Scholar]

[14] Samycia M, Lin AN. Efficacy of topical calcineurin inhibitors in lichen planus. J Cutan Med Surg 2012;16(4):221-9. [PubMed] [Google Scholar]

[15] Eckardt A, Volker B, Starke O, Kaever V, Kapp A. Topical Tacrolimus in erosive oral lichen planus: An effective treatment approach. Oral Bioscience and Medicine 2005;4:235-40. [Google Scholar]

[16] Rouxel AM, Le Toux G, Misery L. Tacrolimus en bains de bouche dans le traitement de seconde intention du lichen plan buccal érosif. Ann Dermatol Venereol 2010;137(10):648-9. [CrossRef] [PubMed] [Google Scholar]

[17] Baubion E, Doutre MS, Beylot-Barry M. Lichen plan buccal et tacrolimus en bains de bouche. Ann Dermatol Venereol 2009; 136(3):276-8. [CrossRef] [PubMed] [Google Scholar]

[18] Olivier V, Lacour JP, Mousnier A, Garraffo R, Monteil RA, Ortonne JP. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 2002;138:1335-8. [CrossRef] [PubMed] [Google Scholar]